The carboxy-terminal cross-linked telopeptide of type I collagen (ICTP) is a potential serum marker of ongoing liver fibrosis

Clinica Chimica Acta

Volumn 248, Issue 2, 1996, Pages 187-195

  Ricard Blum, Sylvie ^a   Chossegros, Philippe ^b   Guerret, Sylviane ^a   Trepo, Christian ^b   Grimaud, Jean Alexis ^a   Chevallier, Michèle ^a  

^a CNRS   (France)

^b HÔTEL DIEU   (France)

Author keywords

carboxy terminal telopeptide of type I collagen (ICTP); fibrosis; liver; serum marker; type I collagen

Indexed keywords

COLLAGEN TYPE 1; MARKER;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; COLLAGEN DEGRADATION; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0029883553     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(95)06253-X     Document Type: Article

References (14)

1. Schuppan D. Connective tissue polypeptides in serum as parameters to monitor antifibrotic treatment in hepatic fibrogenesis. J Hepatol 1991;13(Suppl. 3):S17-S25.
2. Hartmann DJ, Trinchet JC, Ricard-Blum S, Beaugrand M, Callard P, Ville G. Radioimmunoassay of type I collagen that mainly detects degradation products in serum: application to patients with liver diseases. Clin Chem 1990;36:421-426.
3. Murawaki Y, Koda M, Yamada S, Kawasaki H, Shima H, Burkhardt H. Serum collagenase activity in patients with chronic liver disease. J Hepatol 1993;18:328-334.
4. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993;394:636-640.
5. Ricard-Blum S, Bresson-Hadni S, Vuitton DA, Ville G, Grimaud JA. Hydroxypyridinium collagen cross-links in human liver fibrosis: study of alveolar echinococcosis. Hepatology 1992;15:599-602.
6. Ricard-Blum S, Ville G, Grimaud JA. Pyridinoline, a mature collagen cross-link, in fibrotic livers from Schistosoma mansoni-infected mice. Am J Trop Med Hyg 1992;47:816-820.
7. Ricard-Blum S, Liance M, Houin R, Grimaud JA, Vuitton DA. Covalent cross-linking of liver collagen by pyridinoline increases in the course of experimental alveolar echinococcosis. Parasite 1995;2:113-118.
8. Chevallier M, Guerret S, Chossegros P, Gérard F, Grimaud JA. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 1994;20:349-355.
9. Knodell R, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-435.
10. Talonpoika JT, Hämäläinen MM. Type I collagen carboxyterminal telopeptide in human gingival crevicular fluid in different clinical conditions and after periodontal treatment. J Clin Periodontol 1994;21:320-326.
11. Babbs C, Hunt LP, Haboubi NY, Smith A, Rowan BP, Warnes TW. Type III procollagen peptide: a marker of disease activity in primary biliary cirrhosis. Lancet 1988;i:1021-1024.
12. Niemelä O, Risteli L, Sotaniemi EA, Stenbäck F, Risteli J. Serum basement membrane and type III procollagen-related antigens in primary biliary cirrhosis. J Hepatol 1988;6:307-314.
13. Mutimer DJ, Bassendine MF, Kelly P, James OFW. Is measurement of type III procollagen amino propeptide useful in primary biliary cirrhosis? J Hepatol 1989;9:184-189.
14. Guéchot J, Poupon RE, Giral P, Balkau B, Giboudeau J, Poupon R. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatol 1994;20:388-393.